Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, View ORCID ProfileAndi Krumbholz
doi: https://doi.org/10.1101/2021.07.09.21260251
Ruben Rose
1Institut für Infektionsmedizin, Christian-Albrechts-Universität zu Kiel und Universitätsklinikum Schleswig Holstein, Campus Kiel, Brunswiker Straße 4, D-24105 Kiel, Germany
Franziska Neumann
2Labor Dr. Krause und Kollegen MVZ GmbH, Steenbeker Weg 23, D-24106 Kiel, Germany
Olaf Grobe
2Labor Dr. Krause und Kollegen MVZ GmbH, Steenbeker Weg 23, D-24106 Kiel, Germany
Thomas Lorentz
2Labor Dr. Krause und Kollegen MVZ GmbH, Steenbeker Weg 23, D-24106 Kiel, Germany
Helmut Fickenscher
1Institut für Infektionsmedizin, Christian-Albrechts-Universität zu Kiel und Universitätsklinikum Schleswig Holstein, Campus Kiel, Brunswiker Straße 4, D-24105 Kiel, Germany
Andi Krumbholz
1Institut für Infektionsmedizin, Christian-Albrechts-Universität zu Kiel und Universitätsklinikum Schleswig Holstein, Campus Kiel, Brunswiker Straße 4, D-24105 Kiel, Germany
2Labor Dr. Krause und Kollegen MVZ GmbH, Steenbeker Weg 23, D-24106 Kiel, Germany

Article usage
Posted July 13, 2021.
Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
medRxiv 2021.07.09.21260251; doi: https://doi.org/10.1101/2021.07.09.21260251
Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz
medRxiv 2021.07.09.21260251; doi: https://doi.org/10.1101/2021.07.09.21260251
Subject Area
Subject Areas
- Addiction Medicine (434)
- Allergy and Immunology (758)
- Anesthesia (222)
- Cardiovascular Medicine (3312)
- Dermatology (282)
- Emergency Medicine (479)
- Epidemiology (13397)
- Forensic Medicine (19)
- Gastroenterology (900)
- Genetic and Genomic Medicine (5174)
- Geriatric Medicine (482)
- Health Economics (785)
- Health Informatics (3283)
- Health Policy (1145)
- Hematology (432)
- HIV/AIDS (1022)
- Medical Education (478)
- Medical Ethics (128)
- Nephrology (525)
- Neurology (4949)
- Nursing (262)
- Nutrition (734)
- Oncology (2530)
- Ophthalmology (730)
- Orthopedics (284)
- Otolaryngology (348)
- Pain Medicine (323)
- Palliative Medicine (90)
- Pathology (547)
- Pediatrics (1305)
- Primary Care Research (558)
- Public and Global Health (7525)
- Radiology and Imaging (1713)
- Respiratory Medicine (981)
- Rheumatology (480)
- Sports Medicine (425)
- Surgery (551)
- Toxicology (72)
- Transplantation (237)
- Urology (206)